Ambulatory 7-day mechanical circulatory support in sheep model of pulmonary hypertension and right heart failure

被引:1
作者
Ukita, Rei [1 ]
Patel, Yatrik J. [1 ]
Wu, W. Kelly [1 ]
Francois, Sean A. [1 ]
Cortelli, Michael [1 ]
Johnson, Carl A. [1 ]
Cardwell, Nancy [1 ]
Talackine, Jennifer R. [1 ]
Stokes, John W. [1 ]
Grogan, William [2 ]
Mentz, Meredith [1 ]
Tracy, Kaitlyn M. [1 ]
Harris, Timothy R. [1 ]
Tucker, William [1 ]
Simonds, Elizabeth [3 ]
Demarest, Caitlin T. [4 ]
Cook, Keith E. [5 ]
Skoog, David J. [6 ]
Rosenzweig, Erika B. [7 ]
Bacchetta, Matthew [1 ,8 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Cardiac Surg, 1215 21st Ave South,Suite 5025, Nashville, TN 37232 USA
[2] Auburn Univ, Auburn, AL USA
[3] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Nashville, TN 37232 USA
[5] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA USA
[6] Adv Resp Technol Inc, Pittsburgh, PA USA
[7] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA
[8] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA
关键词
mechanical circulatory; pulmonary; right heart failure; extracorporeal; membrane oxygenation; ventricular assist device; (VAD); sheep; (ECMO); hypertension; ambulation; EXTRACORPOREAL MEMBRANE-OXYGENATION; ARTIFICIAL LUNG; ASSIST DEVICE; TRANSPLANTATION; OXYRVAD; BRIDGE; ARTERY;
D O I
10.1016/j.healun.2023.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Right heart failure is the major cause of death in pulmonary hypertension. Lung transplantation is the only long-term treatment option for patients who fail medical therapy. Due to the scarcity of donor lungs, there is a critical need to develop durable mechanical support for the failing right heart. A major design goal for durable support is to reduce the size and complexity of devices to facilitate ambulation. Toward this end, we sought to deploy wearable mechanical support technology in a sheep disease model of chronic right heart failure. METHODS: In 6 sheep with chronic right heart failure, a mechanical support system consisting of an extracorporeal blood pump coupled with a gas exchange unit was attached in a right atrium-to-left atrium configuration for up to 7 days. Circuit performance, hematologic parameters, and animal hemodynamics were analyzed. RESULTS: Six subjects underwent the chronic disease model for 56 to 71 days. Three of the subjects survived to the 7-day end-point for circulatory support. The circuit provided 2.8 (0.5) liter/min of flow compared to the native pulmonary blood flow of 3.5 (1.1) liter/min. The animals maintained physiologically balanced blood gas profile with a sweep flow of 1.2 (1.0) liter/min. Two animals freely ambulated while wearing the circuit. CONCLUSIONS: Our novel mechanical support system provided physiologic support for a large animal model of pulmonary hypertension with right heart failure. The small footprint of the circuit and the low sweep requirement demonstrate the feasibility of this technology to enable mobile ambulatory applications. J Heart Lung Transplant 2024;43:293-302 (c) 2023 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 50 条
  • [41] Long-term mechanical circulatory support for advanced heart failure: the tide is turning
    Slaughter, Mark S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (10) : 1080 - 1081
  • [42] Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support
    Catino, Anna B.
    Ferrin, Peter
    Wever-Pinzon, James
    Horne, Benjamin D.
    Wever-Pinzon, Omar
    Kfoury, Abdallah G.
    McCreath, Lauren
    Diakos, Nikolaos A.
    McKellar, Stephen
    Koliopoulou, Antigone
    Bonios, Michael J.
    Al-Sarie, Mohammad
    Taleb, Iosif
    Dranow, Elizabeth
    Fang, James C.
    Drakos, Stavros G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (01) : 164 - 174
  • [43] The future of mechanical circulatory support for advanced heart failure
    Marinescu, Karolina K.
    Uriel, Nir
    Adatya, Sirtaz
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (03) : 321 - 328
  • [44] Mechanical Circulatory Support Heart Failure Therapy "in Motion"
    Ensminger, Stephan M.
    Gerosa, Gino
    Gummert, Jan F.
    Falk, Volkmar
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2016, 11 (05) : 305 - 314
  • [45] Mechanical circulatory support devices in the treatment of heart failure
    Knight, JL
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (03): : 410 - 417
  • [46] Statistics of heart failure and mechanical circulatory support in 2020
    Bowen, Robert E. S.
    Graetz, Thomas J.
    Emmert, Daniel A.
    Avidan, Michael S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (13)
  • [47] Evolution of Mechanical Circulatory Support for advanced heart failure
    Moeller, Cathrine M.
    Valledor, Andrea Fernandez
    Oren, Daniel
    Rubinstein, Gal
    Sayer, Gabrial T.
    Uriel, Nir
    PROGRESS IN CARDIOVASCULAR DISEASES, 2024, 82 : 135 - 146
  • [48] Physiologic Benefits of Pulsatile Perfusion During Mechanical Circulatory Support for the Treatment of Acute and Chronic Heart Failure in Adults
    Guan, Yulong
    Karkhanis, Tushar
    Wang, Shigang
    Rider, Alan
    Koenig, Steven C.
    Slaughter, Mark S.
    El Banayosy, Aly
    Undar, Akif
    ARTIFICIAL ORGANS, 2010, 34 (07) : 529 - 536
  • [49] Levosimendan in pulmonary hypertension and right heart failure
    Hansen, Mona Sahlholdt
    Andersen, Asger
    Nielsen-Kudsk, Jens Erik
    PULMONARY CIRCULATION, 2018, 8 (03)
  • [50] Role of Durable Mechanical Circulatory Support for the Management of Advanced Heart Failure
    Waqas, Muhammed
    Cowger, Jennifer A.
    HEART FAILURE CLINICS, 2016, 12 (03) : 399 - +